The week in health tech, explained in plain English.Get the free newsletter →
November 12, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

CMS Finalizes 2.4% Home Health Pay Bump for 2027

CMS on Nov. 4 finalized its Home Health Prospective Payment System rule for 2027, setting a 2.4% payment increase for home health agencies, according to Becker's Hospital Review. The bump gives providers modest relief after years of pressure on Medicare reimbursement in the post-acute sector.

The rule pairs higher payments with stricter oversight. CMS included tougher Medicare provider enrollment provisions, part of a broader federal push to curb alleged fraud, waste and abuse across the healthcare system. Home health has drawn scrutiny from regulators and watchdogs, and the new enrollment requirements are designed to screen out bad actors before they bill Medicare.

For home health operators, the update means planning around a defined rate for 2027 while preparing for added compliance and enrollment hurdles. The combination reflects CMS's dual strategy: adjust reimbursement to keep agencies viable while raising the bar for who can participate in the program. Agencies should review the final rule closely to gauge both the financial impact and new administrative obligations.

More in Government

Government

Democrats Float 'Medicare for Kids' Ahead of 2026 Midterms

Democrats are floating a narrower "Medicare for Kids" proposal alongside the broader Medicare for All push as healthcare shapes the 2026 midterm debate.

Why it matters: The direction of Democratic healthcare policy could reshape coverage, reimbursement, and payer dynamics across the industry depending on 2026 election outcomes.

Government

BIO Sues to Block Medicare Peer-Country Drug Pricing Pilot

BIO has sued to block a Medicare pilot that ties certain US drug prices to peer-country benchmarks, the latest challenge to Trump's most-favored-nation pricing push.

Why it matters: The outcome will shape how far the federal government can use Medicare pilots to push US drug prices toward what other countries pay.

Government

CMS Makes Medicare Drug Price Negotiation Rules Permanent

CMS finalized a rule making its Medicare Drug Price Negotiation Program framework permanent, setting lasting policies for negotiated prices starting in 2029.

Why it matters: A permanent framework gives drugmakers, payers, and providers a stable rulebook to plan pricing and contracting around instead of chasing year-by-year changes.